Early outcomes of tocilizumab in adults hospitalized with severe COVID-19 - The Vall d’Hebron COVID-19 prospective cohort study
View ORCID ProfileAdrián Sánchez-Montalvá, Júlia Sellarés-Nadal, View ORCID ProfileJuan Espinosa-Pereiro, View ORCID ProfileNuria Fernández-Hidalgo, View ORCID ProfileSantiago Pérez-Hoyos, Fernando Salvador, Xavier Durà, Marta Miarons, View ORCID ProfileAndrés Antón, Simeón Eremiev-Eremiev, Abiu Sempere-González, Arnau Monforte-Pallarés, View ORCID ProfilePau Bosch-Nicolau, Salvador Augustin, Júlia Sampol, Alfredo Guillén-del-Castillo, Benito Almirante
doi: https://doi.org/10.1101/2020.05.07.20094599
Adrián Sánchez-Montalvá
1Infectious Diseases Department, Vall d’Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain
8International Health Program of the Catalan Institut of Health (PROSICS), Barcelona, Spain
9Tropical Medicine Spanish Research Network (RICET), Madrid, Spain
MD, PhDJúlia Sellarés-Nadal
1Infectious Diseases Department, Vall d’Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain
MDJuan Espinosa-Pereiro
1Infectious Diseases Department, Vall d’Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain
8International Health Program of the Catalan Institut of Health (PROSICS), Barcelona, Spain
MDNuria Fernández-Hidalgo
1Infectious Diseases Department, Vall d’Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain
10Infectous Diseases Spanish Research Network (REIPI), Madrid, Spain
MD, PhDSantiago Pérez-Hoyos
2Statistic Unit, Vall d’Hebron Institute of Research, Barcelona, Spain
PhDFernando Salvador
1Infectious Diseases Department, Vall d’Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain
8International Health Program of the Catalan Institut of Health (PROSICS), Barcelona, Spain
9Tropical Medicine Spanish Research Network (RICET), Madrid, Spain
MD, PhDXavier Durà
1Infectious Diseases Department, Vall d’Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain
MDMarta Miarons
3Pharmacy Department, Vall d’Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain
Pharm D, PhDAndrés Antón
4Microbiology Department, Vall d’Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain
10Infectous Diseases Spanish Research Network (REIPI), Madrid, Spain
PhDSimeón Eremiev-Eremiev
1Infectious Diseases Department, Vall d’Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain
MDAbiu Sempere-González
1Infectious Diseases Department, Vall d’Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain
MDArnau Monforte-Pallarés
1Infectious Diseases Department, Vall d’Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain
MDPau Bosch-Nicolau
1Infectious Diseases Department, Vall d’Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain
MDSalvador Augustin
5Hepatology Department, Vall d’Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain
MD, PhDJúlia Sampol
6Pneumology Department, Vall d’Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain
MDAlfredo Guillén-del-Castillo
7Internal Medicine Department, Vall d’Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain
MD, PhDBenito Almirante
1Infectious Diseases Department, Vall d’Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain
10Infectous Diseases Spanish Research Network (REIPI), Madrid, Spain
MD, PhD![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Article usage
Posted July 10, 2020.
Early outcomes of tocilizumab in adults hospitalized with severe COVID-19 - The Vall d’Hebron COVID-19 prospective cohort study
Adrián Sánchez-Montalvá, Júlia Sellarés-Nadal, Juan Espinosa-Pereiro, Nuria Fernández-Hidalgo, Santiago Pérez-Hoyos, Fernando Salvador, Xavier Durà, Marta Miarons, Andrés Antón, Simeón Eremiev-Eremiev, Abiu Sempere-González, Arnau Monforte-Pallarés, Pau Bosch-Nicolau, Salvador Augustin, Júlia Sampol, Alfredo Guillén-del-Castillo, Benito Almirante
medRxiv 2020.05.07.20094599; doi: https://doi.org/10.1101/2020.05.07.20094599
Early outcomes of tocilizumab in adults hospitalized with severe COVID-19 - The Vall d’Hebron COVID-19 prospective cohort study
Adrián Sánchez-Montalvá, Júlia Sellarés-Nadal, Juan Espinosa-Pereiro, Nuria Fernández-Hidalgo, Santiago Pérez-Hoyos, Fernando Salvador, Xavier Durà, Marta Miarons, Andrés Antón, Simeón Eremiev-Eremiev, Abiu Sempere-González, Arnau Monforte-Pallarés, Pau Bosch-Nicolau, Salvador Augustin, Júlia Sampol, Alfredo Guillén-del-Castillo, Benito Almirante
medRxiv 2020.05.07.20094599; doi: https://doi.org/10.1101/2020.05.07.20094599
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (669)
- Anesthesia (181)
- Cardiovascular Medicine (2650)
- Dermatology (223)
- Emergency Medicine (400)
- Epidemiology (12234)
- Forensic Medicine (10)
- Gastroenterology (760)
- Genetic and Genomic Medicine (4109)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2661)
- Health Policy (1005)
- Hematology (364)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (439)
- Neurology (3890)
- Nursing (210)
- Nutrition (578)
- Oncology (2037)
- Ophthalmology (585)
- Orthopedics (241)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1116)
- Primary Care Research (452)
- Public and Global Health (6536)
- Radiology and Imaging (1407)
- Respiratory Medicine (871)
- Rheumatology (410)
- Sports Medicine (343)
- Surgery (450)
- Toxicology (53)
- Transplantation (185)
- Urology (166)